Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance
Flexible, scalable sales teams for rapid product launch

& lifecycle management
Real-time insights
powered by a one-of-a-kind comprehensive qualitative database — AnswerY

Premium content & audience access to critical oncology care networks

Continuous growth for teams and individuals led by pharma industry experts

Biosimilars Immunology

Omnichannel Product Launch

Download PDF
Create an omnichannel pharma product launch strategy to grow a new biosimilar in a crowded market.
OUR TASK
Develop and deliver original scientific content; deploy through digital channels + sales outreach. Segment HCPs by mindset. Reach audiences with the right messages. Use an AI-powered tool to analyze field feedback and update messaging.
Download PDF
The Ask
CLIENT
Global
Mid-Sized BioPharma
A creative team develops an omnichannel strategy for a pharma product launch.
Omnichannel Pharma Launch Strategy
Create and implement a marketing and messaging strategy across digital, medical, and sales teams to reach HCPs.
Stand Out
Ensure content and messaging differentiates the product within a crowded market.
Monitor Success
Adjust materials as needed in response to market feedback.
The Approach
TOOLS
Omnichannel Strategy
Insights-Gathering
doctor using mobile to check onmichannel marketing.
HCP Segmentation
Segment customers by mindset, through their current knowledge of biosimilars, behaviors, and channel preferences.
Original Scientific Content
Develop original scientific content geared towards differing HCP personas to best support behavioral change.
Leverage Multiple Channels, Adjust Responsively
Leverage email, social media communities, microsites, Congress presentations, video, and sales tools. Use “Interview With An Innovator” custom content to share KOL best practices with HCPs.
The Results
OUTCOME
Richer Insights
HCP Behavior Change
Sales team looking at theraputic sales results.
Impressive Sales Results
Product reached second-highest therapeutic volume during the first quarter after launch, out of 7 similar products that launched simultaneously. Product selected as 1 of 3 biosimilars on a widely accepted formulary.
Powerful KOL Reach + Partnerships
In less than 12 months, engaged 80-plus key opinion leaders (KOLs) and developed partnerships with 2 associations and 2 large medical groups.
Brand Awareness Growth
From our work, more than 3,000 gastroenterologists and rheumatologists became aware of the new-to-the-U.S. brand.
High Rep Engagement
Achieved 100% sales team engagement, leading to high satisfaction and plans to use Amplity AskX for future launches.

Read Next

Read More arrow
Read More arrow